Immune disorders

Neutrophilis Acute bacterial infections Immune disorder Viral infections... 

The first gene therapy trial was conducted in September 1990. A 4-year-old girl with SCID (an inherited immune disorder disease, otherwise known as the bubble boy syndrome) was treated in Cleveland, Ohio. She is doing well some 10 years after the treatment. A second girl with the same disorder underwent gene therapy and she too continues to do well. 

The progress in understanding TGF-fl signaling roles and mechanisms resulted in applications in medicine and biotechnology, including artificial intervention into stem cell growth and differentiation, or development of new generations of pharmaceutical compositions for tissue restoration and treatment of such diseases as cancer, cardiovascular or renal dysfunctions, and immune disorders. 

First human gene therapy performed, in an effort to treat a child with an immune disorder... 

Control of signaling pathways by small molecules in the cell is also at the basis of modem strategies of drug discovery. Much sought to this concern are small molecules that control IgE signaling pathways and are known to be involved in immune disorders. 

Momordica charantia L. Ku Gua (Bitter melon) (seed) Anti-HIV protein MAP 30, sterol.33 351 408 423 For immune disorders and common infections. Capable of inhibiting infection of HIV-1 in T. lymphocytes and monocytes, anti-tumor. 

Rhincodon Typus (Smith, Liver, cartilage, Immunity disorders,... 

MSCs offer several advantages for the treatment of GVHD and inflammatory and immune disorders. The ease of isolation, in vitro expansion, genetic stability, and ability to escape alloimmunity, make MSCs a model of choice for cellular therapy and also for gene... 

Marx. J. "Cell Communication Failure Leads in Immune Disorder." Science. 896 iFebruaiy 12. 1993). 

Prchal JT. 2003. Delivery on demand - A new era of gene therapy NEJM. 348 1282-1283. Preuss MA, Curiel DT. 2007. Gene therapy Science fiction or reality South Med J. 100 101-104. Puck JM, Malech HL. 2006. Gene therapy for immune disorders Good news tampered by bad news. J All Clin Immunol. 117 865-869. 

At least five molecular classes of insulin antibodies may be produced during the course of insulin therapy in diabetes IgA, IgD, IgE, IgG, and IgM. There are two major types of immune disorders in these patients ... 

Fernandez D, Bonilla E, Phillips P, Perl A (2006) Endocr Metab Immune Disord Drug Targets 6 305... 

It is forecast that up to the end of the current decade, the research focus regarding therapeutic mAbs will be on two categories oncology and arthritis, and inflammatory and immune disorders. A significant increase of sales is expected up to 2008 for chimeric mAbs, in absolute terms, and for human and humanized mAbs, in relative terms (Figure 16.2). Up to now, murine mAbs are those with the lowest approval rate (4.5%), whereas the chimeric are the most successful (26%). The approval rates for humanized mAbs (18%) and human antibodies (14%) were intermediate. However, as most of the last two types are still under development, the approval situation may change significantly in the future (Reichert and Pavlou, 2004). 

Buelow R, Woo J (2002) Carbon monoxide-generating compounds for treatment of vascular, inflammatory and immune disorders. Patent WO 2002/078684... 

Thyroid disorders may be divided into over- and underproduction of the thyroid hormones. These may be caused by thyroid gland disorders or disorders of the pituitary gland (TSH production) or hypothalamus (thyrotropin-releasing hormone release). Thyroid hormone deficiency in infancy may cause mental retardation if it is not corrected immediately after birth. For this reason, many states require thyroid function tests in all newborns. In adults, thyroid deficiency may be caused by Hashimoto s thyroiditis, an immune disorder, or dietary iodine deficiency, in which case it is called simple goiter. The term "myxedema" has been used to refer to hypothyroidism of whatever cause. Myxedemas may... 

---